NCT06842563View on ClinicalTrials.gov

Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical Trial

Active, not recruitingOBSERVATIONAL
Enrollment

900

Participants

Timeline

Start Date

February 25, 2025

Primary Completion Date

November 20, 2025

Study Completion Date

December 20, 2025

Conditions
Hepatocellular Carcinoma (HCC)
Trial Locations (1)

Unknown

Zhongshan Hospital Affiliated to Fudan University in Shanghai, Shanghai

All Listed Sponsors
collaborator

Shanghai Zhongshan Hospital

OTHER

collaborator

The Affiliated Hospital of Xuzhou Medical University

OTHER

lead

Singlera Genomics Inc.

INDUSTRY

NCT06842563 - Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical Trial | Biotech Hunter | Biotech Hunter